Abeona Therapeutics (ABEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2005 | 09-2005 | 06-2005 | 03-2005 | 12-2004 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 349 | 378 | 784 | 2,888 | 1,775 |
| Marketable Securities | 125 | 92 | 504 | 472 | 486 |
| Receivables | 4,488 | 765 | 810 | 764 | 77 |
| Inventories | N/A | 44 | 61 | 113 | N/A |
| Other current assets | 0 | -1,732 | 0 | 0 | 0 |
| TOTAL | $5,159 | $192 | $2,986 | $5,194 | $3,160 |
| Non-Current Assets | |||||
| PPE Net | 300 | 864 | 930 | 982 | 464 |
| Intangibles | 1,121 | 4,018 | 4,114 | 4,212 | 3,207 |
| Other Non-Current Assets | 633 | 1,005 | 1,198 | 1,373 | 4,259 |
| TOTAL | $2,054 | $5,887 | $6,242 | $6,567 | $7,930 |
| Total Assets | $7,213 | $7,811 | $9,228 | $11,761 | $11,090 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 106 | N/A | N/A | N/A | 8,341 |
| Accounts payable and accrued liabilities | 2,883 | 2,113 | 2,255 | 1,800 | 1,728 |
| Accrued Expenses | 652 | 567 | 878 | 572 | 311 |
| TOTAL | $3,814 | $11,398 | $15,900 | $14,668 | $10,553 |
| Non-Current Liabilities | |||||
| Long Term Debt | 7,636 | 37 | 113 | 152 | 5,603 |
| Deferred Revenues | 173 | 1,880 | 1,904 | 1,428 | 173 |
| Other Non-Current Liabilities | 0 | 9,515 | 5,500 | 5,500 | 1,595 |
| TOTAL | $7,636 | $9,552 | $5,613 | $5,652 | $7,198 |
| Total Liabilities | $11,450 | $20,950 | $21,513 | $20,320 | $17,751 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 3 | 3 | 3 | 3 | 2 |
| Common Shares | 35 | 176 | 157 | 157 | 155 |
| Retained earnings | -66,165 | -72,736 | -70,673 | -66,887 | -64,465 |
| Other shareholders' equity | -1,049 | -1,228 | -1,277 | -1,337 | -1,361 |
| TOTAL | $-4,237 | $-13,139 | $-12,285 | $-8,559 | $-6,661 |
| Total Liabilities And Equity | $7,213 | $7,811 | $9,228 | $11,761 | $11,090 |